{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:53:32Z","timestamp":1777031612066,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.advms.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T21:20:15Z","timestamp":1437168015000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Copeptin: Pathophysiology and potential clinical impact"],"prefix":"10.1016","volume":"60","author":[{"given":"Ewelina","family":"\u0141ukaszyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2015.07.002_bib0400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:18:3:223","article-title":"Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport","volume":"18","author":"Acher","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.advms.2015.07.002_bib0405","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc2337","article-title":"Science review: vasopressin and the cardiovascular system part 1 \u2013receptor physiology","volume":"7","author":"Holmes","year":"2003","journal-title":"Crit Care"},{"key":"10.1016\/j.advms.2015.07.002_bib0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/cc2338","article-title":"Science review: vasopressin and the cardiovascular system part 2 \u2013 clinical physiology","volume":"8","author":"Holmes","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.advms.2015.07.002_bib0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1022564803093","article-title":"Structure\u2013function relationships of the vasopressin prohormone domains","volume":"18","author":"de Bree","year":"1998","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0420","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1172\/JCI112898","article-title":"Human platelet fraction arginine-vasopressin. Potential physiological role","volume":"79","author":"Bichet","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.advms.2015.07.002_bib0425","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ki.1986.126","article-title":"Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure","volume":"29","author":"Bichet","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.advms.2015.07.002_bib0430","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1432-1033.1972.tb01918.x","article-title":"A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization","volume":"28","author":"Holwerda","year":"1972","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.advms.2015.07.002_bib0435","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.advms.2015.07.002_bib0440","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.advms.2015.07.002_bib0445","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1210\/jc.2007-0232","article-title":"Changes in plasma copeptin, the C-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects","volume":"92","author":"Szinnai","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.advms.2015.07.002_bib0450","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2014-2295","article-title":"Comparison between copeptin and vasopressin in the population from the community and in people with chronic kidney disease","volume":"99","author":"Roussel","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.advms.2015.07.002_bib0455","first-page":"341","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level","volume":"29","author":"Katan","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.advms.2015.07.002_bib0460","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1741-7015-10-7","article-title":"The role of copeptin as a diagnostic and prognostic biomarker for the risk stratification in emergency department","volume":"10","author":"Nickel","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.advms.2015.07.002_bib0465","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.advms.2015.07.002_bib0470","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000326902","article-title":"Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease","volume":"34","author":"Meijer","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.advms.2015.07.002_bib0475","doi-asserted-by":"crossref","first-page":"172","DOI":"10.11613\/BM.2013.021","article-title":"Copeptin and its potential role in diagnosis and prognosis of various diseases","volume":"23","author":"Dobsa","year":"2013","journal-title":"Biochem Med"},{"key":"10.1016\/j.advms.2015.07.002_bib0480","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.ajkd.2012.08.038","article-title":"Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort","volume":"61","author":"Boertien","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.advms.2015.07.002_bib0485","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1093\/ndt\/gfs070","article-title":"Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease","volume":"27","author":"Boertien","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.advms.2015.07.002_bib0490","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2215\/CJN.08690813","article-title":"Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patient","volume":"9","author":"Zittema","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.advms.2015.07.002_bib0495","first-page":"182","article-title":"Copeptin in hemodialyzed patients","volume":"14","author":"Ma\u0142yszko","year":"2010","journal-title":"Nefrol Dial Pol"},{"key":"10.1016\/j.advms.2015.07.002_bib0500","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1016\/j.transproceed.2010.09.031","article-title":"Copeptin in relation to New York Heart Association class in heart transplant recipients and kidney transplant recipients","volume":"42","author":"Malyszko","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.advms.2015.07.002_bib0505","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","article-title":"Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stage of the disease","volume":"52","author":"Neuhold","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort","volume":"77","author":"Meijer","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.advms.2015.07.002_bib0515","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","article-title":"Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malm\u00f6 Diet and Cancer Study cardiovascular cohort","volume":"37","author":"Enh\u00f6rning","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/j.advms.2015.07.002_bib0520","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1681\/ASN.2014030260","article-title":"Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study","volume":"26","author":"Ponte","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.advms.2015.07.002_bib0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123093","article-title":"Renal function interferes with copeptin in prediction of major adverse cardiac events in patients undergoing vascular surgery","volume":"10","author":"Schrimpf","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.advms.2015.07.002_bib0530","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11883-014-0421-5","article-title":"Copeptin \u2013 marker of acute myocardial infarction","volume":"16","author":"Mockel","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.advms.2015.07.002_bib0535","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","article-title":"Incremental value of copeptin for rapid rule out of acute myocardial infarction","volume":"54","author":"Reichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.advms.2015.07.002_bib0540","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ijcard.2012.12.039","article-title":"Copeptin and cardiovascular disease: a review of a novel neurohormone","volume":"167","author":"Yalta","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0545","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2014.01.436","article-title":"A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction","volume":"113","author":"Lipinski","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0550","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","article-title":"Early discharge using single cardiac troponin and copeptin test in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study","volume":"36","author":"Mockel","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.advms.2015.07.002_bib0555","doi-asserted-by":"crossref","first-page":"614145","DOI":"10.1155\/2015\/614145","article-title":"Copeptin testing in acute myocardial infarction: ready for routine use?","volume":"2015","author":"Reinstadler","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.advms.2015.07.002_bib0560","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.04.133","article-title":"Incremental value of copeptin to highly sensitive cardiac troponin I for rapid rule-out of myocardial infarction","volume":"190","author":"Wildi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2015.01.333","article-title":"Serum copeptin level can be helpful biomarker in evaluation of myocardial perfusion scintigraphy results","author":"Ede","year":"2015","journal-title":"Cardiol J"},{"key":"10.1016\/j.advms.2015.07.002_bib0570","article-title":"Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial","author":"Marston","year":"2015","journal-title":"Emerg Med J"},{"key":"10.1016\/j.advms.2015.07.002_bib0575","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.2011.666","article-title":"Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure","volume":"305","author":"Alehagen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.advms.2015.07.002_bib0580","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2362.2006.01724.x","article-title":"Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure","volume":"36","author":"Stoiser","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.advms.2015.07.002_bib0585","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jacc.2008.03.050","article-title":"Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease","volume":"52","author":"Neuhold","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0590","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/eurheartj\/ehp098","article-title":"C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study","volume":"30","author":"Voors","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.advms.2015.07.002_bib0595","first-page":"145","article-title":"Copeptin and kidney function in patients with chronic heart failure","volume":"20","author":"Malyszko","year":"2014","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0600","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3760\/cma.j.issn.0366-6999.20122497","article-title":"Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease","volume":"126","author":"Li","year":"2013","journal-title":"Chin Med J"},{"key":"10.1016\/j.advms.2015.07.002_bib0605","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00467-013-2683-5","article-title":"Serum copeptin levels in adolescents with primary hypertension","volume":"29","author":"Tenderenda-Banasiuk","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.advms.2015.07.002_bib0610","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/HJH.0000000000000610","article-title":"Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults","volume":"33","author":"Schoen","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.advms.2015.07.002_bib0615","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1447-0756.2010.01498.x","article-title":"Circulating levels of copeptin, a novel biomarker in pre-eclampsia","volume":"37","author":"Zulfikaroglu","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.advms.2015.07.002_bib0620","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejogrb.2012.08.012","article-title":"Maternal and neonatal copeptin levels at cesarean section and vaginal delivery","volume":"165","author":"Foda","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.advms.2015.07.002_bib0625","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000361016","article-title":"Cardiovascular biomarkers in preeclampsia at triage","volume":"36","author":"Wellmann","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.advms.2015.07.002_bib0630","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/HYPERTENSIONAHA.114.03848","article-title":"Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model","volume":"64","author":"Santillan","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.advms.2015.07.002_bib0635","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/HYPERTENSIONAHA.114.03762","article-title":"Increased levels of copeptin before clinical diagnosis of preeclampsia","volume":"64","author":"Yeung","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.advms.2015.07.002_bib0640","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.21783","article-title":"Copeptin: a novel, independent prognostic marker in patients with ischemic stroke","volume":"66","author":"Katan","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.advms.2015.07.002_bib0645","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/STROKEAHA.110.584649","article-title":"Prognostic value of copeptin: one-year outcome in patients with acute stroke","volume":"41","author":"Urwyler","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2015.07.002_bib0650","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/ane.12132","article-title":"Plasma copeptin and long-term outcomes in acute ischemic stroke","volume":"12","author":"Zhang","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.advms.2015.07.002_bib0655","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/WNL.0b013e31820b75e6","article-title":"Stress hormones predict cerebrovascular re-events after transient ischemic attacks","volume":"76","author":"Katan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2015.07.002_bib0660","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1161\/STROKEAHA.114.005584","article-title":"Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study","volume":"45","author":"De Marchis","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2015.07.002_bib0665","doi-asserted-by":"crossref","first-page":"e53191","DOI":"10.1371\/journal.pone.0053191","article-title":"Copeptin as a marker for severity and prognosis of aneurysmal subarachnoid hemorrhage","volume":"8","author":"Fung","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.advms.2015.07.002_bib0670","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cca.2014.03.014","article-title":"Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage","volume":"433","author":"Yu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.advms.2015.07.002_bib0675","doi-asserted-by":"crossref","first-page":"e48309","DOI":"10.1371\/journal.pone.0048309","article-title":"Copeptin, procalcitonin and routine inflammatory markers \u2013 predictors of infection after stroke","volume":"7","author":"Fluri","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.advms.2015.07.002_bib0680","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/CIRCULATIONAHA.109.909663","article-title":"Plasma copeptin and the risk of diabetes mellitus","volume":"121","author":"Enh\u00f6rning","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.advms.2015.07.002_bib0685","doi-asserted-by":"crossref","first-page":"E1065","DOI":"10.1210\/jc.2010-2981","article-title":"Plasma copeptin, a unifying factor behind the metabolic syndrome","volume":"96","author":"Enh\u00f6rning","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.advms.2015.07.002_bib0690","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ahj.2014.11.020","article-title":"Copeptin is an independent predictor of diabetic heart disease and death","volume":"169","author":"Enh\u00f6rning","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.advms.2015.07.002_bib0695","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.2337\/dc12-2165","article-title":"Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31)","volume":"36","author":"Riphagen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.advms.2015.07.002_bib0700","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2015.04.134","article-title":"Use of copeptin and high-sensitive cardiac troponin T for diagnosis and prognosis in patients with diabetes mellitus and suspected acute myocardial infarction","volume":"190","author":"Zellweger","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.advms.2015.07.002_bib0705","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-013-2922-0","article-title":"Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)","volume":"56","author":"Boertien","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.advms.2015.07.002_bib0710","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2337\/dc13-0683","article-title":"Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria","volume":"36","author":"Velho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.advms.2015.07.002_bib0715","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/1479164114544464","article-title":"Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients","volume":"11","author":"Bar-Shalom","year":"2014","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.advms.2015.07.002_bib0720","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","article-title":"Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections","volume":"37","author":"M\u00fcller","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.advms.2015.07.002_bib0725","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00134-007-0895-5","article-title":"Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ","volume":"33","author":"Kr\u00fcger","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.advms.2015.07.002_bib0730","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/dkp148","article-title":"C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia \u2013 influence of antibiotic pre-treatment: results from the German competence network CAPNETZ","volume":"64","author":"Kr\u00fcger","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.advms.2015.07.002_bib0735","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.rmed.2012.06.008","article-title":"Copeptin predicts clinical deterioration and persistent instability in community acquired pneumonia","volume":"106","author":"Kolditz","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.advms.2015.07.002_bib0740","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/cc6780","article-title":"Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia","volume":"12","author":"Seligman","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.advms.2015.07.002_bib0745","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1590\/S1806-37132011000400012","article-title":"Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia","volume":"37","author":"Seligman","year":"2011","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.advms.2015.07.002_bib0750","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jcrc.2011.07.081","article-title":"The Sequential Organ Failure Assessment score and copeptinfor predicting survival in ventilator-associated pneumonia","volume":"27","author":"Boeck","year":"2012","journal-title":"J Crit Care"},{"key":"10.1016\/j.advms.2015.07.002_bib0755","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1378\/chest.06-2336","article-title":"Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.advms.2015.07.002_bib0760","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jcms.2015.03.031","article-title":"Can we use serum copeptin levels as a biomarker in obstructive sleep apnea syndrome?","volume":"43","author":"Selcuk","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.advms.2015.07.002_bib0765","first-page":"589","article-title":"Copeptin: a new predictor for severe obstructive sleep apnea","volume":"11","author":"\u00c7\u0131narka","year":"2015","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"10.1016\/j.advms.2015.07.002_bib0770","first-page":"1721","article-title":"The serum copeptin levels in obstructive sleep apnea patients with prehypertensive","volume":"19","author":"Akkoyun","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.advms.2015.07.002_bib0775","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","article-title":"Copeptin in the differential diagnosis of hyponatremia","volume":"94","author":"Fenske","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"October","key":"10.1016\/j.advms.2015.07.002_bib0780","first-page":"w13270","article-title":"The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases","volume":"141","author":"Nigro","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.advms.2015.07.002_bib0785","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/jc.2010-2345","article-title":"Copeptin in the differential diagnosis of the polydipsia\u2013polyuria syndrome\u2014revisiting the direct and indirect water deprivation tests","volume":"96","author":"Fenske","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.advms.2015.07.002_bib0790","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"Katan","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112615000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112615000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T22:05:04Z","timestamp":1717970704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112615000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1896112615000383"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2015.07.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.728831174.793537893","asserted-by":"object"}]},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copeptin: Pathophysiology and potential clinical impact","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Medical University of Bialystok. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}